PL
ASND icon

Parkwood LLC’s Ascendis Pharma A/S ASND Stock Holding History

Parkwood LLC’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,696
Closed -$1.87M – 88
2024
Q2 		$1.87M Buy
13,696
+1,449
+12% +$197K 0.23% 69
2024
Q1 		$1.85M Sell
12,247
-3,849
-24% -$549K 0.17% 110
2023
Q4 		$2.03M Sell
16,096
-2,001
-11% -$200K 0.24% 70
2023
Q3 		$1.7M Sell
18,097
-515
-3% -$48.2K 0.18% 68
2023
Q2 		$1.66M Sell
18,612
-66
-0.4% -$5.74K 0.3% 64
2023
Q1 		$2M Buy
18,678
+1,125
+6% +$129K 0.28% 74
2022
Q4 		$2.14M Sell
17,553
-2,876
-14% -$334K 0.33% 67
2022
Q3 		$2.11M Buy
20,429
+2,824
+16% +$268K 0.32% 72
2022
Q2 		$1.64M Sell
17,605
-1,215
-6% -$115K 0.29% 78
2022
Q1 		$2.21M Sell
18,820
-1,972
-9% -$228K 0.36% 66
2021
Q4 		$2.8M Sell
20,792
-3,380
-14% -$503K 0.48% 62
2021
Q3 		$3.85M Buy
24,172
+5,992
+33% +$820K 0.47% 61
2021
Q2 		$2.39M Sell
18,180
-3,030
-14% -$404K 0.28% 71
2021
Q1 		$2.73M Sell
21,210
-4,104
-16% -$624K 0.48% 56
2020
Q4 		$4.22M Sell
25,314
-32,928
-57% -$5.45M 0.51% 59
2020
Q3 		$5.84M Buy
58,242
+25,081
+76% +$3.61M 0.9% 36
2020
Q2 		$4.91M Buy
+33,161
New +$4.55M 0.88% 36

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Parkwood LLC's ASND Position: Q3 2024 in Review

Parkwood LLC sold out of Ascendis Pharma A/S (ASND) in Q3 2024, closing a stake of 13,696 shares — an estimated $1.87M sold.

Parkwood LLC first reported a position in ASND in Q2 2020 and held it in 17 quarters. The position peaked at $5.84M in Q3 2020. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.

  • Parkwood LLC reported no remaining Ascendis Pharma A/S position as of Q3 2024 after selling out during the quarter.
  • Parkwood LLC sold 13,696 Ascendis Pharma A/S shares in Q3 2024, an estimated $1.87M.
  • Parkwood LLC first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 17 quarters.
  • Parkwood LLC's Ascendis Pharma A/S position peaked at $5.84M in Q3 2020.
  • 219 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2024.

Based on Parkwood LLC's 13F filing for Q3 2024, filed 14 Nov 2024.